OAKLAND, Calif.--(BUSINESS WIRE)--Marqeta (NASDAQ: MQ), the global modern card issuing platform, announced today that it has..
News and Video Search Results
You might like
Expected media coverage
Anti-Bb Antibody (NM8074) Receives US FDA Clearance to Start Clinical Trial in Naïve aHUS Patients (Rare Disease)
-- FDA Clears Initiation of Efficacy Trial in aHUS (Atypical Hemolytic Uremic Syndrome) Patients· An Efficacy Trial in Adult aHUS..
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The..